Navigation Links
CIVCO Appoints Hap Peterson Vice President of North American Sales for Radiation Oncology

CORALVILLE, Iowa, March 11, 2013 /PRNewswire/ -- CIVCO Medical Solutions is pleased to announce the appointment of Hap Peterson as vice president of North American sales for the radiation oncology (RO) business unit, responsible for managing CIVCO's sales activities in the United States and Canada.


Peterson comes to CIVCO with over 25 years of medical sales and sales management experience with companies including Medtronic, U.S. Surgical Corporation, Synthes Spine and most recently Boston Scientific Neuromodulation where he managed a 100 person area sales, operations and clinical team and was responsible for the successful financial performance and profitability of the assigned area.

"As CIVCO continues to grow, it is imperative for us to engage an industry-leading sales executive with a history of delivering outstanding results," said Nat Geissel , senior vice president and general manager, RO. "Hap Peterson not only has vast experience directing the development, revenue growth and profitability of numerous organizations, but also understands the value of fostering long-term customer relationships."

Peterson is based at CIVCO's corporate location in Coralville, Iowa. He holds a Bachelor of Arts in communications from the University of Iowa in Iowa City.

About CIVCOCIVCO Medical Solutions has over 30 years of experience and offers cutting-edge medical technology to a diverse group of medical professionals.  CIVCO's Radiation Oncology (RO) division designs, manufactures and markets comprehensive motion management solutions to improve patient outcomes and increase clinical productivity for head & neck, breast, lung, abdomen, prostate and other treatment sites. RO's products include couchtops and overlays for linear accelerators and imaging systems, advanced patient immobilization solutions, robotic patient positioning, advanced fiducial markers, and immobilization/positioning equipment and consumables. The Multi-Modality Imaging (MMI) unit designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures, with a strong focus on ultrasound. MMI's products range from infection control products including a wide range of ultrasound and CT covers to device guidance, positioning and electromagnetic needle tracking.  CIVCO offers patients and clinicians the newest and best technology available to improve patient care. For further information please contact:Kelly HazelettMarketing Communications SpecialistCIVCO Medical SolutionsTel: 319-248-6529kelly.hazelett@civco.comPHOTOGRAPHY AVAILABLE ON REQUEST.


SOURCE CIVCO Medical Solutions
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CIVCO Showcases "Clearly Different" Products at AAPM 2012 Booth #217
2. CIVCO Medical Solutions Appoints Senior Vice President and General Managers to Business Units
3. CIVCO Releases Non-Invasive Stereotactic Radiosurgery (SRS) Solution for Head and Brain Tumors
4. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
5. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
6. Nephros Appoints John C. Houghton as President and Chief Executive Officer
7. Elsevier Appoints New President of Elsevier CPM Resource Center
8. GenWay Biotech Appoints New Vice President of Custom/OEM
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
11. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
Post Your Comments:
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):